ANGELA CALLAHAN: Open Payments
NPI 1083935753 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$863 in 39 payments from 14 companies in 2025. Trend: 2023 $1,234 · 2024 $945 · 2025 $863
Food & beverage: $863
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $210 |
| ABBVIE INC. | 9 | $186 |
| Boston Scientific Corporation | 1 | $144 |
| Lilly USA, LLC | 2 | $50 |
| SANOFI-AVENTIS U.S. LLC | 1 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Amgen Inc. | 2 | $34 |
| Exact Sciences Corporation | 1 | $34 |
| PFIZER INC. | 2 | $31 |
| Globus Medical, Inc. | 1 | $26 |
Products named: FARAPULSE, UBRELVY, Ozempic, QULIPTA, Rybelsus, JARDIANCE, TZIELD, XIFAXAN.
Industry payments across FL — which companies pay providers there.
